Delivery Order SPE2DB20D2104-SPE2DB25FMTNZ
- Not listed
- AmerisourceBergen Drug Corp was awarded a Delivery Order valued at $27,194.41 by the Defense Logistics Agency (DLA) on May 6, 2025, for the supply of Miebo 100% eye drop (3mL) with an ultimate completion date of May 7, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. Performance will occur at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,897.98 for Miebo 100% eye drop (3mL) under a firm fixed price contract. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside delivery order represents a competitive award to the pharmaceutical distributor for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Miebo 100% eye drop medication in 3 mL units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,325.38 with a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The order represents...
- The Defense Logistics Agency awarded a $5,322.00 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop (3ml) on September 3, 2025, with completion by September 4, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting...
- The Defense Logistics Agency awarded a $1,227.37 firm fixed price delivery order to AmerisourceBergen Drug Corp for Miebo 100% Eye Drop 3ML, a pharmaceutical product for ophthalmic use. The delivery order, awarded on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a child contract issued under a larger indefinite delivery vehicle. This non-competitive award was placed with performance at the contractor's Conshohocken, Pennsylvania facility, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Miebo 100% eye drop solution in 3ml quantities. The contract carries a ceiling value of $23,965.92 and represents a firm fixed-price delivery order with an ultimate completion date of August 15, 2025. This award is a non-set-aside contract, meaning it was competitively awarded and available to all eligible vendors. The performance location is AmerisourceBergen's corporate...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Miebo 100% eye drops (3 mL), with a ceiling value of $18,826.55. The contract utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating competitive award based on AmerisourceBergen's demonstrated capability to meet federal procurement requirements. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Miebo 100% eye drop solution in 3ml units. This competitively awarded, non-set-aside contract carries a ceiling value of $7,183.12 and is structured as a firm fixed price delivery order with an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $9,567.86 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Miebo 100% eye drop medication in 3 milliliter units. This is a firm fixed price contract with no set-aside designation, reflecting open competition based on AmerisourceBergen's demonstrated capability to meet federal procurement requirements. The contract is set for ultimate completion on September 11, 2025, and will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,072.18 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed-price contract with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a small-value delivery order under the company's larger pharmaceutical supply vehicle with DLA. This delivery order is issued...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMTNZDelivery Order
AmerisourceBergen Drug Corp was awarded a $3,202.62 delivery order by the Defense Logistics Agency (DLA) on June 18, 2025, for the supply of Miebo 100% eye drop medication in 3ml quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 20, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This award is issued as a child delivery order under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen Drug Corp to supply a broad range of medications and medical supplies to support military healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard. The company's status as a major pharmaceutical distributor and consistent receipt of competitive awards across multiple therapeutic domains demonstrates its capability to fulfill federal medical supply requirements at scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 6/18/25 |